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risk factors including dyslipidemia, obesity, elevated blood pressure,
fatty liver, and elevated blood glucose levels. A common feature in
these conditions is the dysregulation of metabolic processes. In this
issue of eBioMedicine, Joachim Herz and colleagues demonstrate that
loss of the LDL Receptor-Related Protein (LRP1) in the liver primes
mice for a range of metabolic dysfunctions. These ﬁndings suggest
that physiological actions of LRP1 normally serve to protect against
development of the metabolic syndrome (Ding et al., 2016).
LRP1 was ﬁrst identiﬁed by Herz et al. in 1988 on the basis of its
sequence homology with the LDL receptor (Herz et al., 1988). Conse-
quently, much of the research into LRP1 function has been focused on
lipid metabolism and its effects on atherosclerosis. In the liver, LRP1
clears the remnants of triglyceride-rich lipoproteins (chylomicrons
and very low-density lipoproteins), after they have delivered their
payload of triglyceride to peripheral tissues. In the endothelium, LRP1
has been linked to the intracellular transport of a range of cell-surface
receptors, and this action has also been proposed to protect against
the development and progression of atherosclerosis. Recently, a proteo-
mics study identiﬁed LRP1 as a component of the glucose transporter
regulatory vesicles in isolated adipocytes (Jedrychowski et al., 2010),
suggesting that LRP1 may have a novel role regulating glucose metabo-
lism. Based on this ﬁnding, Ding et al. hypothesized that liver-speciﬁc
deletion of LRP1 in mice would reveal its importance in systemic
glucose metabolism.
The authors challenged control and liver-speciﬁc LRP1-deﬁcient
mice with a high-fat diet (60% of the calories derived from fat). Liver-
speciﬁc LRP1 knockout mice had amarked loss of metabolic control rel-
ative to liter-mate controls. The knockout mice were obese, they had
higher fasting glucose levels and reduced glucose clearance, and they
had fatty liver. These phenotypes were linked with decreased VLDL
secretion, and attenuated responses to insulin. Interestingly, when the
authors probed hepatic insulin signaling they observed that the chow-
fed LRP1 knockout mice had more profound perturbations in insulinDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.04.002.
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body glucose and insulin responses.
The authors probed this latter observation further by performing a
hyperinsulinemic-euglycemic clamp studies on mice administered a
short-term high-fat diet to avoid the confounding factor of obesity.
This experiment demonstrated that loss of hepatic LRP1 was sufﬁcient
to uncouple insulin's feedback on the gluconeogenesis pathway, sug-
gesting that the dietary fat somehow primes the LRP1-deﬁcient liver
for insulin resistance.
The authors used primary hepatocytes to interrogate the molecular
mechanisms responsible for the interaction between dietary fat and
LRP1. Previouswork demonstrated that insulin stimulated the transport
of LRP1 to the cell surface in a variety of cell types, and that this
translocation is essential for the internalization of the insulin receptor
in neurons. Ding et al. conﬁrmed that LRP1 is required for normal cell
surface localization of the insulin receptor in hepatocytes; however,
loss of LRP1 in did not affect insulin receptor internalization in the
presence or absence of fatty acids. Although the authors were unable
to pinpoint precisely how LRP1 interacts with dietary fats to affect
insulin signaling, they did observe that palmitate, but not oleate or
linoleate, was able to attenuate the cell-surface localization of LRP1 in
response to insulin. Future studies based on this ﬁnding should be
able to tease out the interaction between saturated fatty acids, LRP1,
and insulin receptor signaling.
Ding et al. also revealed the potential for LRP1 to regulate the traf-
ﬁcking of the glucose transporter GLUT2 to the cell surface. Glucose is
transported across the plasmamembrane by three members of a family
of transmembrane receptors. All cells have low-level expression of a
high-afﬁnity transporter, GLUT1, which is proposed to maintain basal
glucose uptake. Adipose and muscle cells express GLUT4, another
high-afﬁnity transporter that is translocated to the cell surface in
response to post-prandial hyperglycemia. Hepatocytes express GLUT2,
a low-afﬁnity high-capacity bidirectional transporter that is proposed
to be the dominant means of glucose transport in liver (Efeyan et al.,
2015; Thorens, 2015). This functionality allows the liver to take up
glucose after feeding and release gluconeogenesis-derived de novo
glucose while fasting. GLUT2 levels are thought to be regulated primar-
ily through a transcriptional mechanism; however, studies in the intes-
tine suggest that GLUT2 translocation from the basolateral to the apical
membrane may facilitate uptake from the lumen in response to feeding
(Kellett and Helliwell, 2000; Leturque et al., 2009).
Ding et al. demonstrated that loss of LRP1 reduced the cell-
surface localization of GLUT2 in primary hepatocytes in the presencethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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which hepatocytes respond to hyperglycemia. The model proposed
by Ding et al. is consistent with previous reports that mice lacking
hepatic GLUT2 have a reduced capacity to clear glucose from the
bloodstream but maintain output of newly synthesized glucose
from the liver while fasting (Seyer et al., 2013). Similarly, deletion
of hepatic LRP1 reduced the clearance of a bolus of glucose but did
not affect hepatic glucose output.
Our understanding of the biological functions of the lipoprotein
receptor superfamily has advanced a great deal since the original iden-
tiﬁcation of the LDL receptor. Structurally related proteins of the LDLR
superfamily, including LRP-1, have now been implicated in a range of
cellular processes. The studies of Ding et al., build on this progress by
implicating LRP-1 in glucose transporter trafﬁcking and hepatic metab-
olism in vivo. In the future it will be important to better deﬁne exactly
how LRP-1 affects the cellular movement of GLUT2 and perhaps other
membrane proteins. The question of whether the LRP-1 pathway
could be targeted for therapeutic beneﬁt in the setting of the metabolic
syndrome also remains to be addressed.
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